Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: A leading manufacturer and distributor of fragrances, cosmetics, and health and beauty aids, operating in both prestige and mass market segments. The company holds exclusive worldwide licenses for Celine and Christian Lacroix fragrances.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Net Sales | $28.42 million | $31.04 million |
| Gross Margin | $13.71 million (48.2%) | $15.61 million (50.3%) |
| Operating Income | $3.82 million | $3.74 million |
| Net Income | $2.01 million | $2.03 million |
| Diluted EPS | $0.10 | $0.10 |
| Cash from Operations | $3.60 million | $4.51 million |
| Cash and Equivalents (End of Period) | $31.49 million | $30.18 million |
| Working Capital | $70.39 million | N/A |
| Long-Term Debt | $1.35 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 8.4% year-over-year. At comparable exchange rates, sales decreased 5%. The decline is attributed to the lack of major new launches in Q1 2002 compared to the 40% growth in Q1 2001 driven by the rollout of Paul Smith and Burberry Touch.
- Margin Compression: Gross margin percentage dropped from 50.3% to 48.2% due to a lower mix of high-margin prestige fragrance sales.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased 17% to $9.89 million, improving from 38% of sales in 2001 to 35% in 2002. This was driven by reduced advertising spend following the September 11th impact and fixed cost leverage from increased mass market sales.
- Mass Market Growth: Despite the overall sales decline, mass market product sales increased 9% due to the expansion of the Intimate health line and the Aziza cosmetics line.
Outlook, Risks, and Contingencies
- Contemplated Acquisition: The company received court approval to acquire mass market fragrance brands and inventory from Tristar Corporation (a Debtor-in-Possession) for approximately $8.2 million ($3.5 million for IP, $4.7 million for inventory). Closing is expected prior to June 1, 2002. This includes a manufacturing agreement and a non-competition agreement with the Tristar management team.
- Product Pipeline: New launches include FUBU Plush, a Burberry baby line, and the Christian Lacroix "Bazar" fragrance line. A Celine bath line is scheduled for Q3 2002.
- Dividend Initiation: The Board approved a cash dividend program; the first quarterly dividend of $0.015 per share was paid on April 15, 2002.
- Risks: Key risks include the successful execution of the Tristar acquisition, currency fluctuations (hedged via forward contracts), and dependence on strategic partners (LV Capital/LVMH).
Investor Verification Checklist
- Confirm the closing date and final terms of the Tristar Corporation asset acquisition.
- Monitor the performance of new product launches (Bazar, FUBU Plush) in upcoming quarters to offset the prestige sales decline.
- Verify the impact of the new dividend program on future cash flow projections.
- Review the effectiveness of cost-cutting measures in SG&A as a percentage of sales in subsequent periods.